Bromelin

Phase 1Small molecule

UUniversidade Federal de Pernambuco

Bromelin is one of 12 small molecule programs targeting Pseudomyxoma Peritonei. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Pseudomyxoma PeritoneiActive, not recruiting

Pseudomyxoma PeritoneiPhase 1

Active, not recruiting

Competition

Competitive Landscape

13 competitors in Pseudomyxoma Peritonei

#DrugCompanyPhaseTrials

Cytoxan

BBaxter Healthcare Corporation

Mitosol

Acetadote

AArbor Pharmaceuticals, Inc.

Phase 2

1 4

Xeloda

EEngelhard Arzneimittel GmbH & Co.KG

Phase 2

1 5

FOLFOX

AstraZeneca

Phase 2

1 6

Cryoprecipitate

CSL Behring

Phase 3

1 7

Beyfortus

BeiGene

Phase 1

1 8

Cysteine Hydrochloride

Novartis

Phase 1

1 9

Intraperitoneal 5FU

WWashington University School of Medicine

Phase 2

1 10

Bromelain

IIndiana University

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pseudomyxoma Peritonei1 trial

Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

Unknown status·MMaimónides Biomedical Research Institute of Córdoba·Phase 1·NCT04982146·10 enrolled

Acute Cough1 trial

Bromelin, a Compound Prepared With Ananas Comocus Extract and Honey, for Acute Cough

Unknown status·UUniversidade Federal de Pernambuco·Phase 4·NCT01356693·102 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Bromelin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bromelin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bromelin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Universidade Federal de Pernambuco company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: UUniversidade Federal de Pernambuco

Bromelin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pseudomyxoma Peritonei1 trial

Acute Cough1 trial

References

Drug Info

Quick Facts

Related News